bioRxivImmunologyPreprint
Tissue-specific tolerance mechanisms and lymph node co-drainage converge to shape T cell immunity in the upper digestive system and regulate pancreatic cancer progression
Yixuan D. Zhou, Z. Peter WangiD, Emily Schaffer, Macy R. KomnickiD, Hailey M. BrowniD, Gwen M. TayloriD, Kay L. FiskeiD, Colin S. SheehaniD, Terence S. DermodyiD, Alexander MuiriD, Daria EsterházyiD
- Citations
- 0
Abstract
The liver, pancreas, and duodenum share lymph nodes (LNs), providing a unique system to examine how tissue origin of self-antigens shapes T cell fate. Comparing mice expressing ovalbumin (OVA) from distinct subcellular compartments, we found that cytosolic OVA from liver or pancreas, but not gut, was immunologically ignored. High-dose hepatic secreted OVA triggered antigen-specific T cell deletion, whereas secreted pancreatic and intestinal OVA induced regulatory T (Treg) cells, revealing immunological ignorance, clonal deletion and Treg cell generation as tissue-specific tolerance mechanisms. Of these, LN co-drainage only influenced Treg cell induction, establishing gut-pancreas-liver axes: Intestinal viral infection rendered hepatocyte- and exocrine pancreas-specific T cells inflammatory; liver injury promoted pancreas- and gut-directed responses. These self-reactive T cells caused tissue destruction but enhanced pancreatic tumor control when neoantigen OVA was secreted but not cytosolic. Thus, LN co-drainage and tissue-specific tolerance mechanisms jointly shape immune homeostasis and disease susceptibility in the upper digestive system.
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tissue-resident regulatory T cells exert dualistic anti-tumour and pro-repair function in the exocrine pancreas
J. Stockis, T. Yip, … T. Y. F. Halim·bioRxiv·Feb 15, 2024
- Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer
Paige C. Arneson‐Wissink, Alexandra Q. Bartlett, … Aaron J. Grossberg·Cellular and Molecular Gastroenterology and HepatologyPeer-reviewed·Jan 1, 2026
- Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing
N. Frey, L. Tortola, … G. Schwank·bioRxiv·Jul 29, 2021
- Progranulin promotes immune evasion of pancreatic adenocarcinoma through regulation of MHCI expression
P. F. Cheung, J. Yang, … J. T. Siveke·bioRxiv·Feb 24, 2021
- Immune responses in pancreatic cancer may be restricted byprevalence of activated regulatory T-cells, dysfunctionalCD8+ T-cells, and senescent T-cells
S. Sivakumar, E. Abu-Shah, … M. Dustin·bioRxiv·Jun 20, 2020
- Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset
Gregory J. Golden, Vincent H. Wu, … Michael R. Betts·Nature CommunicationsPeer-reviewed·May 18, 2025